Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Graphene Oxide Coatings as Tools to Prevent Microbial Biofilm Formation on Medical Device.

Cacaci M, Martini C, Cinzia G, Torelli R, Bugli F, Sanguinetti M.

Adv Exp Med Biol. 2019 Aug 30. doi: 10.1007/5584_2019_434. [Epub ahead of print]

PMID:
31468360
2.

Antibiofilm Activity of Three Different Irrigation Techniques: An in Vitro Study.

Eneide C, Castagnola R, Martini C, Grande NM, Bugli F, Patini R, Cordaro M, Sanguinetti M, Olivi G, Isola G, Marigo L.

Antibiotics (Basel). 2019 Aug 9;8(3). pii: E112. doi: 10.3390/antibiotics8030112.

3.

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

Fallacara AL, Zamperini C, Podolski-Renić A, Dinić J, Stanković T, Stepanović M, Mancini A, Rango E, Iovenitti G, Molinari A, Bugli F, Sanguinetti M, Torelli R, Martini M, Maccari L, Valoti M, Dreassi E, Botta M, Pešić M, Schenone S.

Cancers (Basel). 2019 Jun 19;11(6). pii: E848. doi: 10.3390/cancers11060848.

4.

Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens.

Buonocore F, Picchietti S, Porcelli F, Della Pelle G, Olivieri C, Poerio E, Bugli F, Menchinelli G, Sanguinetti M, Bresciani A, Gennari N, Taddei AR, Fausto AM, Scapigliati G.

Dev Comp Immunol. 2019 Jul;96:9-17. doi: 10.1016/j.dci.2019.02.012. Epub 2019 Feb 18.

PMID:
30790604
5.

A protein chimera self-assembling unit for drug delivery.

Amalfitano A, Martini C, Nocca G, Papi M, De Spirito M, Sanguinetti M, Vitali A, Bugli F, Arcovito A.

Biotechnol Prog. 2019 Mar;35(2):e2769. doi: 10.1002/btpr.2769. Epub 2018 Dec 27.

PMID:
30575331
6.

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites.

Palmieri V, Bugli F, Cacaci M, Perini G, Maio F, Delogu G, Torelli R, Conti C, Sanguinetti M, Spirito M, Zanoni R, Papi M.

Nanomedicine (Lond). 2018 Nov;13(22):2867-2879. doi: 10.2217/nnm-2018-0183. Epub 2018 Nov 15.

PMID:
30431405
7.

Expression profiling in a mammalian host reveals the strong induction of genes encoding LysM domain-containing proteins in Enterococcus faecium.

Cacaci M, Giraud C, Leger L, Torelli R, Martini C, Posteraro B, Palmieri V, Sanguinetti M, Bugli F, Hartke A.

Sci Rep. 2018 Aug 17;8(1):12412. doi: 10.1038/s41598-018-30882-z.

8.

Erratum: Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel.

Papi M, Palmieri V, Bugli F, De Spirito M, Sanguinetti M, Ciancico C, Braidotti MC, Gentilini S, Angelani L, Conti C.

Sci Rep. 2017 Jun 1;7(1):2779. doi: 10.1038/s41598-017-00063-5.

9.

Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistant Staphylococcus aureus.

Bugli F, Cacaci M, Palmieri V, Di Santo R, Torelli R, Ciasca G, Di Vito M, Vitali A, Conti C, Sanguinetti M, De Spirito M, Papi M.

Interface Focus. 2018 Jun 6;8(3):20170059. doi: 10.1098/rsfs.2017.0059. Epub 2018 Apr 20.

10.

Different effects of matrix degrading enzymes towards biofilms formed by E. faecalis and E. faecium clinical isolates.

Torelli R, Cacaci M, Papi M, Paroni Sterbini F, Martini C, Posteraro B, Palmieri V, De Spirito M, Sanguinetti M, Bugli F.

Colloids Surf B Biointerfaces. 2017 Oct 1;158:349-355. doi: 10.1016/j.colsurfb.2017.07.010. Epub 2017 Jul 9.

PMID:
28715766
11.

Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.

Papi M, Caputo D, Palmieri V, Coppola R, Palchetti S, Bugli F, Martini C, Digiacomo L, Pozzi D, Caracciolo G.

Nanoscale. 2017 Jul 27;9(29):10327-10334. doi: 10.1039/c7nr03042h.

PMID:
28702661
12.

The Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2.

Jamet A, Dervyn R, Lapaque N, Bugli F, Perez-Cortez NG, Blottière HM, Twizere JC, Sanguinetti M, Posteraro B, Serror P, Maguin E.

Sci Rep. 2017 Jul 4;7(1):4581. doi: 10.1038/s41598-017-04875-3.

13.

Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel.

Papi M, Palmieri V, Bugli F, De Spirito M, Sanguinetti M, Ciancico C, Braidotti MC, Gentilini S, Angelani L, Conti C.

Sci Rep. 2016 Dec 5;6(1):12. doi: 10.1038/s41598-016-0010-7. Erratum in: Sci Rep. 2017 Jun 1;7(1):2779.

14.

Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance.

Poerio N, Bugli F, Taus F, Santucci MB, Rodolfo C, Cecconi F, Torelli R, Varone F, Inchingolo R, Majo F, Lucidi V, Mariotti S, Nisini R, Sanguinetti M, Fraziano M.

Sci Rep. 2017 Mar 27;7:45120. doi: 10.1038/srep45120.

15.

Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome.

Pedicino D, Severino A, Ucci S, Bugli F, Flego D, Giglio AF, Trotta F, Ruggio A, Lucci C, Iaconelli A, Paroni Sterbini F, Biasucci LM, Sanguinetti M, Glieca F, Luciani N, Massetti M, Crea F, Liuzzo G.

Int J Cardiol. 2017 Jun 1;236:95-99. doi: 10.1016/j.ijcard.2017.02.040. Epub 2017 Feb 16.

PMID:
28268083
16.

Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.

Paroni Sterbini F, Palladini A, Masucci L, Cannistraci CV, Pastorino R, Ianiro G, Bugli F, Martini C, Ricciardi W, Gasbarrini A, Sanguinetti M, Cammarota G, Posteraro B.

Appl Environ Microbiol. 2016 Oct 27;82(22):6633-6644. Print 2016 Nov 15.

17.

Serum Endotoxin Activity Measured with Endotoxin Activity Assay Is Associated with Serum Interleukin-6 Levels in Patients on Chronic Hemodialysis.

Bossola M, Di Stasio E, Sanguinetti M, Posteraro B, Antocicco M, Pepe G, Mello E, Bugli F, Vulpio C.

Blood Purif. 2016;42(4):294-300. Epub 2016 Aug 31.

PMID:
27577953
18.

In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm.

Bugli F, Palmieri V, Torelli R, Papi M, De Spirito M, Cacaci M, Galgano S, Masucci L, Paroni Sterbini F, Vella A, Graffeo R, Posteraro B, Sanguinetti M.

Biotechnol Prog. 2016 Nov;32(6):1584-1591. doi: 10.1002/btpr.2339. Epub 2016 Sep 8.

PMID:
27535356
19.

Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences.

Di Simone N, Tersigni C, Cardaropoli S, Franceschi F, Di Nicuolo F, Castellani R, Bugli F, de Waure C, Cavaliere AF, Gasbarrini A, Sanguinetti M, Scambia G, Todros T.

Helicobacter. 2017 Apr;22(2). doi: 10.1111/hel.12347. Epub 2016 Aug 3.

PMID:
27484400
20.

Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.

Brai A, Fazi R, Tintori C, Zamperini C, Bugli F, Sanguinetti M, Stigliano E, Esté J, Badia R, Franco S, Martinez MA, Martinez JP, Meyerhans A, Saladini F, Zazzi M, Garbelli A, Maga G, Botta M.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):5388-93. doi: 10.1073/pnas.1522987113. Epub 2016 Apr 26.

21.

Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.

Deodato D, Maccari G, De Luca F, Sanfilippo S, Casian A, Martini R, D'Arezzo S, Bonchi C, Bugli F, Posteraro B, Vandeputte P, Sanglard D, Docquier JD, Sanguinetti M, Visca P, Botta M.

J Med Chem. 2016 Apr 28;59(8):3854-66. doi: 10.1021/acs.jmedchem.6b00018. Epub 2016 Apr 19.

PMID:
27045868
22.

Overexpression of Enterococcus faecalis elr operon protects from phagocytosis.

Cortes-Perez NG, Dumoulin R, Gaubert S, Lacoux C, Bugli F, Martin R, Chat S, Piquand K, Meylheuc T, Langella P, Sanguinetti M, Posteraro B, Rigottier-Gois L, Serror P.

BMC Microbiol. 2015 May 25;15:112. doi: 10.1186/s12866-015-0448-y.

23.

The polyamine N-acetyltransferase-like enzyme PmvE plays a role in the virulence of Enterococcus faecalis.

Martini C, Michaux C, Bugli F, Arcovito A, Iavarone F, Cacaci M, Paroni Sterbini F, Hartke A, Sauvageot N, Sanguinetti M, Posteraro B, Giard JC.

Infect Immun. 2015 Jan;83(1):364-71. doi: 10.1128/IAI.02585-14. Epub 2014 Nov 10.

24.

An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array.

Ardizzoni A, Posteraro B, Baschieri MC, Bugli F, Sáez-Rosòn A, Manca L, Cacaci M, Paroni Sterbini F, De Waure C, Sevilla MJ, Peppoloni S, Sanguinetti M, Moragues MD, Blasi E.

Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):403-12.

PMID:
25280031
25.

Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.

Bugli F, Caprettini V, Cacaci M, Martini C, Paroni Sterbini F, Torelli R, Della Longa S, Papi M, Palmieri V, Giardina B, Posteraro B, Sanguinetti M, Arcovito A.

Int J Nanomedicine. 2014 May 30;9:2727-39. doi: 10.2147/IJN.S60014. eCollection 2014.

26.

Increased production of gliotoxin is related to the formation of biofilm by Aspergillus fumigatus: an immunological approach.

Bugli F, Paroni Sterbini F, Cacaci M, Martini C, Lancellotti S, Stigliano E, Torelli R, Arena V, Caira M, Posteraro P, Sanguinetti M, Posteraro B.

Pathog Dis. 2014 Apr;70(3):379-89. doi: 10.1111/2049-632X.12152. Epub 2014 Apr 1.

PMID:
24623580
27.

Human monoclonal antibody-based therapy in the treatment of invasive candidiasis.

Bugli F, Cacaci M, Martini C, Torelli R, Posteraro B, Sanguinetti M, Paroni Sterbini F.

Clin Dev Immunol. 2013;2013:403121. doi: 10.1155/2013/403121. Epub 2013 Jun 26. Review.

28.

In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.

Bugli F, Posteraro B, Papi M, Torelli R, Maiorana A, Paroni Sterbini F, Posteraro P, Sanguinetti M, De Spirito M.

Antimicrob Agents Chemother. 2013 Mar;57(3):1275-82. doi: 10.1128/AAC.01875-12. Epub 2012 Dec 21.

29.

Detection of biofilm-grown Aspergillus fumigatus by means of atomic force spectroscopy: ultrastructural effects of alginate lyase.

Papi M, Maiorana A, Bugli F, Torelli R, Posteraro B, Maulucci G, De Spirito M, Sanguinetti M.

Microsc Microanal. 2012 Oct;18(5):1088-94. doi: 10.1017/S1431927612001067. Epub 2012 Oct 2.

PMID:
23026204
30.

The PavA-like fibronectin-binding protein of Enterococcus faecalis, EfbA, is important for virulence in a mouse model of ascending urinary tract infection.

Torelli R, Serror P, Bugli F, Paroni Sterbini F, Florio AR, Stringaro A, Colone M, De Carolis E, Martini C, Giard JC, Sanguinetti M, Posteraro B.

J Infect Dis. 2012 Sep 15;206(6):952-60. doi: 10.1093/infdis/jis440. Epub 2012 Jul 10.

PMID:
22782954
31.

Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection.

Bugli F, Paroni Sterbini F, Graffeo R, Caridi F, Iantomasi R, Torelli R, Masucci L, Cattani P, Fadda G.

New Microbiol. 2011 Jul;34(3):281-6. Epub 2011 Jul 30.

32.

Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008.

Masucci L, Graffeo R, Bani S, Bugli F, Boccia S, Nicolotti N, Fiori B, Fadda G, Spanu T.

Euro Surveill. 2011 Jun 16;16(24). pii: 19891.

33.

Analysis of heat-induced changes in protein expression of Stenotrophomonas maltophilia K279a reveals a role for GroEL in the host-temperature adaptation.

De Carolis E, Posteraro B, Florio AR, Colonna B, Prosseda G, Bugli F, Lorenzetti SR, Fiscarelli E, Inzitari R, Iavarone F, Castagnola M, Fadda G, Sanguinetti M.

Int J Med Microbiol. 2011 Apr;301(4):273-81. doi: 10.1016/j.ijmm.2010.10.001. Epub 2010 Nov 26.

PMID:
21112247
34.

Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.

Bugli F, Graffeo R, Pescatori M, Paroni Sterbini F, Torelli R, Masucci L, Manzara S, Fadda G.

New Microbiol. 2009 Oct;32(4):341-9.

35.

Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR.

Graffeo R, Masucci L, Bugli F, Damiano F, Pinnetti C, Federico G, Fadda G.

New Microbiol. 2008 Oct;31(4):565-7.

36.

First Italian case of cyclosporiasis in an immunocompetent woman: local acquired infection.

Masucci L, Graffeo R, Siciliano M, Franceschelli A, Bugli F, Fadda G.

New Microbiol. 2008 Apr;31(2):281-4.

37.

Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice.

Bugli F, Graffeo R, Paroni Sterbini F, Torelli R, Masucci L, Sali M, Grasso A, Rufini S, Ricci E, Fadda G, Pescatori M.

Toxicon. 2008 Mar 15;51(4):547-54. doi: 10.1016/j.toxicon.2007.11.014. Epub 2007 Nov 23. Erratum in: Toxicon. 2011 Jan;57(1):191.

PMID:
18187177
38.

Human monoclonal antibody fragment specific for glycoprotein G in herpes simplex virus type 2 with applications for serotype-specific diagnosis.

Bugli F, Manzara S, Torelli R, Graffeo R, Santangelo R, Cattani P, Fadda G.

J Clin Microbiol. 2004 Mar;42(3):1250-3.

39.

Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses.

Desogus A, Burioni R, Ingianni A, Bugli F, Pompei R, Fadda G.

Clin Diagn Lab Immunol. 2003 Jul;10(4):680-5.

40.

A novel expression vector for production of epitope-tagged recombinant Fab fragments in bacteria.

Burioni R, Bugli F, Mancini N, Fadda G.

Hum Antibodies. 2001;10(3-4):149-54.

PMID:
11847426
41.

Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.

Bugli F, Mancini N, Kang CY, Di Campli C, Grieco A, Manzin A, Gabrielli A, Gasbarrini A, Fadda G, Varaldo PE, Clementi M, Burioni R.

J Virol. 2001 Oct;75(20):9986-90.

42.

Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.

Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.

Virology. 2001 Sep 15;288(1):29-35.

43.

Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen.

Bugli F, Bastidas R, Burton DR, Williamson RA, Clementi M, Burioni R.

Hum Immunol. 2001 Apr;62(4):362-7.

PMID:
11295468
44.

A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries.

Burioni R, Plaisant P, Bugli F, Solforosi L, Delli Carri V, Varaldo PE, Fadda G.

Res Virol. 1998 Sep-Oct;149(5):327-30.

PMID:
9879613
45.

Probing the natural antibody repertoire by combinatorial cloning of IgM and IgD isotypes in phage display vectors.

Burioni R, Plaisant P, Bugli F, Delli Carri V, Candela M, Gabrielli A, Fadda G.

Res Virol. 1998 Sep-Oct;149(5):321-5.

PMID:
9879612
46.

A vector for the expression of recombinant monoclonal Fab fragments in bacteria.

Burioni R, Plaisant P, Bugli F, Delli Carri V, Clementi M, Fadda G.

J Immunol Methods. 1998 Aug 1;217(1-2):195-9.

PMID:
9776589
47.

Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.

Burioni R, Plaisant P, Manzin A, Rosa D, Delli Carri V, Bugli F, Solforosi L, Abrignani S, Varaldo PE, Fadda G, Clementi M.

Hepatology. 1998 Sep;28(3):810-4.

PMID:
9731577
48.

Expression cloning and biochemical characterizations of recombinant cyclophilin proteins from Schistosoma mansoni.

Bugli F, Khattab A, Vigneti E, Butler R, Cioli D, Klinkert MQ.

Protein Expr Purif. 1998 Apr;12(3):340-6.

PMID:
9535701
49.

Sequence conservation of schistosome cyclophilins.

Klinkert MQ, Bugli F, Cruz J, Engels B, Cioli D.

Mol Biochem Parasitol. 1996 Oct 30;81(2):239-42. No abstract available.

PMID:
8898338
50.

Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli.

Klinkert MQ, Bugli F, Engels B, Carrasquillo E, Valle C, Cioli D.

Mol Biochem Parasitol. 1995 Dec;75(1):99-111.

PMID:
8720179

Supplemental Content

Support Center